| Dinutuximab studied in …STUDIED_INderived20 of 20show fewer |
|---|
| → studied in | NCT06172296Phase 3 · recruiting Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma · 20 trials list this drug (10 active) | — | — | Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04211675Phase 1/Phase 2 · active not recruiting NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab · 20 trials list this drug (10 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07437963Phase 1/Phase 2 · not yet recruiting Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse · 20 trials list this drug (10 active) | — | — | Ganglioneuroblastoma,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01711554Phase 1 · active not recruiting Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma · 20 trials list this drug (10 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03126916Phase 3 · recruiting Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) · 20 trials list this drug (10 active) | — | — | Ganglioneuroblastoma,Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07261241Phase 2 · not yet recruiting NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab · 20 trials list this drug (10 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06450041Phase 2 · recruiting NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial · 20 trials list this drug (10 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04751383Phase 1 · terminated Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma · 20 trials list this drug (10 active) | — | — | Osteosarcoma,Neuroblastoma,High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03786783Phase 2 · completed Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma · 20 trials list this drug (10 active) | — | — | Ganglioneuroblastoma,High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02573896Phase 1 · active not recruiting Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells · 20 trials list this drug (10 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026312Phase 3 · completed Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma · 20 trials list this drug (10 active) | — | — | Neuroblastoma,Regional Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04238819Phase 1/Phase 2 · completed A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma · 20 trials list this drug (10 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03794349Phase 2 · active not recruiting Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma · 20 trials list this drug (10 active) | — | — | Neuroblastoma,High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04385277Phase 2 · active not recruiting Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL) · 20 trials list this drug (10 active) | — | — | Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03332667Phase 1 · completed MIBG With Dinutuximab +/- Vorinostat · 20 trials list this drug (10 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02484443Phase 2 · completed Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma · 20 trials list this drug (10 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01767194Phase 2 · completed Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma · 20 trials list this drug (10 active) | — | — | Ganglioneuroblastoma,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03098030Phase 2/Phase 3 · completed Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer · 20 trials list this drug (10 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02693171terminated Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients · 20 trials list this drug (10 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01592045Phase 1/Phase 2 · completed ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma · 20 trials list this drug (10 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |